I stay on the cutting edge of industry and enjoy finding out about new companies that major outlets and funds haven't heard of (yet). Most of the time you can find me deep in the corporate filings, focusing on fundamentals that could be behind the next big move in certain stock.
Dr. Jeffrey S. Miller to Present on Progress of GTB-3550 TriKE™ Phase I Trial Accompanying GT Biopharma’s Company Presentation at Raymond James Human Health Innovation Conference
BEVERLY HILLS, Calif., June 21, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT…
